KISS frontman Gene Simmons conducted only the second on-camera press briefing at the Department of Defense in the past year. The last person to stand at the podium was movie star Gerard Butler, who was there in October to promote a new movie.
New York As the frontman of KISS, Gene Simmons occupies rarefied air — a rock star who entertains arenas filled with adoring fans. On Thursday, Simmons joined another exclusive club, conducting only the second on-camera press briefing at the Department of Defense in the last year.
The only other person to stand at the Pentagon Briefing Room podium over the past year? The movie star Gerard Butler, who was there last October to promote a new movie. It's just the latest sign of the Trump administration's ongoing marginalization of the press briefing, long a conduit through which the president and the cabinet have communicated policies and priorities to the news media and the public.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life ItselfEntrepreneurs are taking genetic-editing technology from the lab to the clinic with grand ambitions. But who owns the patents?
Read more »
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life ItselfEntrepreneurs are taking genetic-editing technology from the lab to the clinic with grand ambitions. But who owns the patents? by mtindera07
Read more »
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life ItselfEntrepreneurs are taking genetic-editing technology from the lab to the clinic with grand ambitions. But who owns the patents?
Read more »
How a Chinese Scientist Broke the Rules to Create the First Gene-Edited BabiesDr. He Jiankui, seeking glory for his nation and justice for HIV-positive parents, kept his experiment secret from a doctor, deceived a hospital, ignored Western peers’ warnings and faked a test.
Read more »
Roche pushes back Spark takeover again as regulatory review drags onSwiss drugmaker Roche is pushing back its $4.3 billion takeover offer for gene t...
Read more »
Breakingviews - Three reasons a wonder drug can cost $5 mln(Reuters Breakingviews) - Novartis's gene therapy for spinal muscular atrop...
Read more »
Three reasons a wonder drug can cost $5 mlnNovartis’s gene therapy for a deadly disease looks likely to set a record. There are justifiable factors, like the value it delivers and drugmakers’ high development costs. Then there are less palatable ones, including an inefficient U.S. market with a tolerance for high prices.
Read more »
Chick-fil-A's head of charity reveals his strategy behind donations, how he responds to backlash, and why he believes Christian faith requires inclusivityAs Chick-fil-A faces another wave of protests over its charitable donations this year, Rodney Bullard is at the center of the storm.
Read more »
The man behind Chick-fil-A's charity explains the fast-food chain's donations to groups that critics slam as anti-gayChick-fil-A's charitable donations have been subject to scrutiny for years. The head of Chick-fil-A's charitable giving explains its strategy.
Read more »
The head of Chick-fil-A's charity says the chicken chain would consider working with an LGBT organization if the partnership was 'authentic'Chick-fil-A's head of charity says that the chain would consider working with an LGBT organization if the partnership was impactful and authentic.
Read more »